Inmune Bio, Inc. (INMB) stock
INMBNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
$0.96+0.01 (+1.44%)
Close on Nov 17, 2026Market cap $26.64MP/E –Yield –
Inmune Bio price to book ratio
The price-to-book ratio is market cap divided by shareholders' equity.
Inmune Bio's price to book ratio was 1.5× on Nov 11, 2026, against 1.8× a year earlier. Over the last 5 years it ranged from 1.3× to 6.0×, with a median of 2.4×.
Price to Book Ratio at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2026 | Nov 11, 2026 | 1.5× | −0.1 |
| 2025 | Dec 31, 2025 | 1.6× | −1.0 |
| 2024 | Dec 31, 2024 | 2.7× | −1.9 |
| 2023 | Dec 29, 2023 | 4.6× | +2.8 |
| 2022 | Dec 30, 2022 | 1.8× | −0.3 |
| 2021 | Dec 31, 2021 | 2.1× | −3.6 |
| 2020 | Dec 31, 2020 | 5.6× | +3.1 |
| 2019 | Dec 31, 2019 | 2.5× | – |
See a number that looks wrong?